Breaking News, Financial News

Financial Report: ICON 4Q

In the quarter, income from operations was up 12% to $29.6 million and for the year was $116.3 million (+17%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON 4Q 4Q Revenues: $227 million (+3%) 4Q Earnings: $23.9 million (+14%) FY Revenues: $888 million (+3%) FY Earnings: $91.6 million (+17%) Comments: In the quarter, income from operations was up 12% to $29.6 million and for the year was $116.3 million (+17%). Business awards in the quarter totaled $229 million....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters